LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Hutchmed (China)
HCM
4
New Fortress Energy
NFE
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 23.61%-4.97M | -35.40%-1.08M | -40.39%-1.89M | 57.15%-1.08M | 50.09%-915.71K | 7.57%-6.5M | 59.46%-796.32K | 43.48%-1.35M | -16.06%-2.52M | -258.92%-1.83M |
Net income from continuing operations | 52.69%-7.9M | 71.48%-2.72M | -13.07%-1.68M | 22.39%-2.13M | 53.16%-1.37M | -40.03%-16.71M | -295.22%-9.56M | 72.57%-1.49M | -35.42%-2.75M | -41.01%-2.92M |
Operating gains losses | -93.88%472.22K | -97.77%183.2K | 163.10%278.7K | 208.55%149K | -240.73%-138.68K | 1,481.05%7.72M | 101,698.60%8.2M | -348.79%-441.67K | 81.88%-137.26K | 662.97%98.55K |
Depreciation and amortization | -8.93%300.47K | 4.89%76.38K | 5.45%75.56K | -16.68%74.6K | -22.95%73.93K | -29.24%329.95K | -35.98%72.83K | -38.10%71.65K | -23.84%89.52K | -19.53%95.94K |
Other non cash items | 287.09%2.15M | 274.13%1.01M | 54.04%254.9K | 607.62%585.14K | 726.94%292.74K | -84.80%554.51K | 1,243.81%270.94K | -95.36%165.48K | 39.97%82.69K | 693.21%35.4K |
Change In working capital | -3,405.59%-1.23M | -104.44%-4.55K | -801.34%-1.07M | 78.52%-175.54K | -96.73%17.28K | -116.95%-35.07K | -38.16%102.38K | 115.30%152.07K | -474.76%-817.37K | -35.40%527.85K |
-Change in receivables | 382.86%130.74K | 98.77%-961 | -28.76%18.76K | -107.23%-87 | 2,522.98%113.02K | -5.61%-46.22K | -628.52%-78.07K | 212.65%26.34K | -87.84%1.2K | 122.02%4.31K |
-Change in prepaid assets | -11,437.79%-91.5K | -223.53%-36.81K | -307.08%-16.84K | -168.49%-34.1K | 95.70%-3.74K | 101.74%807 | 49.20%29.8K | 117.99%8.13K | 197.74%49.79K | -391.89%-86.92K |
-Change in payables and accrued expense | -1,412.61%-1.18M | -66.76%56.78K | -883.80%-1.03M | 85.21%-125.59K | -112.08%-76.91K | -78.15%89.86K | -5.89%170.82K | 114.56%131.89K | -380.92%-849.43K | -23.60%636.58K |
-Change in other current liabilities | -8.54%-122.55K | -11.84%-31.91K | -90.34%-43.08K | 11.62%-24.12K | 31.97%-23.45K | 20.23%-112.92K | 15.04%-28.53K | 18.50%-22.64K | 40.63%-27.29K | -0.64%-34.47K |
-Change in other working capital | 0.00%33.4K | -0.01%8.35K | 0.01%8.35K | 0.00%8.35K | 0.00%8.35K | 22.36%33.4K | 0.00%8.35K | -0.01%8.35K | 204.78%8.35K | 6.29%8.35K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 23.61%-4.97M | -35.40%-1.08M | -40.39%-1.89M | 57.15%-1.08M | 50.09%-915.71K | 7.57%-6.5M | 59.46%-796.32K | 43.48%-1.35M | -16.06%-2.52M | -258.92%-1.83M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -351.28%-100K | 0 | 0 | -4,860.32%-100K | 0 | 99.76%-22.16K | 100.00%12 | -97.04%30 | 96.27%-2.02K | -1,054.09%-20.19K |
Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | -1,166.95%-22.16K | --12 | --30 | ---2.02K | -1,054.09%-20.19K |
Net business purchase and sale | ---100K | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -351.28%-100K | --0 | --0 | -4,860.32%-100K | --0 | 99.76%-22.16K | 100.00%12 | -97.04%30 | 96.27%-2.02K | -1,054.09%-20.19K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 58.30%7.64M | 296.69%2.91M | 160.00%2.72M | -53.24%1.07M | 24.90%936.77K | -72.05%4.83M | -91.84%734.01K | -79.65%1.04M | -20.78%2.3M | 223.97%750K |
Net issuance payments of debt | -110.22%-420.47K | -288.55%-688.22K | --0 | -81.44%468.75K | -126.80%-201K | -47.37%4.12M | --365K | -90.10%475K | -13.50%2.53M | 650.00%750K |
Net common stock issuance | 349.78%2.86M | --0 | ---- | ---- | ---- | -13.62%635.39K | --0 | ---- | ---- | ---- |
Net preferred stock issuance | --3.5M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | 2,170.02%1.7M | -72.92%99.95K | -115.58%-141.49K | --605.06K | --1.14M | 125.80%74.95K | --369.01K | 75.37%-65.63K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 58.30%7.64M | 296.69%2.91M | 160.00%2.72M | -53.24%1.07M | 24.90%936.77K | -72.05%4.83M | -91.84%734.01K | -79.65%1.04M | -20.78%2.3M | 223.97%750K |
Net cash flow | ||||||||||
Beginning cash position | -85.66%285.4K | 199.67%1.02M | -69.29%200.57K | -65.56%305.47K | -85.66%285.4K | 146.54%1.99M | -91.32%341.77K | -44.65%653.19K | 68.54%887.03K | 146.54%1.99M |
Current changes in cash | 251.01%2.57M | 3,043.51%1.83M | 370.85%822.99K | 53.08%-108.1K | 101.91%21.06K | -245.02%-1.7M | 96.83%-62.29K | -111.06%-303.85K | -134.42%-230.4K | -292.60%-1.1M |
Effect of exchange rate changes | 136.45%1.45K | -123.67%-1.4K | 108.42%637 | 193.22%3.21K | -189.16%-995 | -139.40%-3.97K | -62.94%5.92K | -180.48%-7.57K | 77.82%-3.44K | 433.97%1.12K |
End cash Position | 900.81%2.86M | 900.81%2.86M | 199.67%1.02M | -69.29%200.57K | -65.56%305.47K | -85.66%285.4K | -85.66%285.4K | -91.32%341.77K | -44.65%653.19K | 68.54%887.03K |
Free cash flow | 23.87%-4.97M | -35.40%-1.08M | -40.39%-1.89M | 57.19%-1.08M | 50.64%-915.71K | 59.31%-6.53M | 92.74%-796.3K | 43.48%-1.35M | -16.15%-2.53M | -261.63%-1.85M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |